Minoryx Therapeutics

MINORYX logotip.jpg

Contact information

Minoryx Therapeutics
Marc Martinell, CEO
TecnoCampus Mataró-Maresme, Av. Ernest Lluch 32, TCM2
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Screening
    • Therapeutic areas
      • Genetic and rare diseases

At Minoryx, we are committed to finding novel treatments for life threatening rare diseases. We prioritize pediatric diseases and we are currently focused on neurometabolic diseases of genetic origin.

Products and services

Minoryx develops a new generation of non-competitive pharmacological chaperones through a proprietary technological platform. As a complementary approach, Minoryx also progress repositioning-based projects.